Show simple item record

Formulation of sustained release oral dosage forms of hydralazine hydrochloride for the treatment of hypertension and cancer

dc.contributor.authorÇelebi, Benek
dc.contributor.authorÜNER, MELIKE
dc.date.accessioned2021-03-02T22:34:36Z
dc.date.available2021-03-02T22:34:36Z
dc.identifier.citationÜNER M., Çelebi B., "Formulation of sustained release oral dosage forms of hydralazine hydrochloride for the treatment of hypertension and cancer", 3rd BBBB, International Conference on Pharmaceutical Sciences, Türkiye, 1 - 04 Ekim 2009
dc.identifier.otherav_0d7a5716-a5d1-4356-8ee9-0b300648d329
dc.identifier.othervv_1032021
dc.identifier.urihttp://hdl.handle.net/20.500.12627/14659
dc.language.isoeng
dc.subjectMeslek Bilimleri
dc.subjectSağlık Bilimleri
dc.subjectEczacılık
dc.subjectFarmakoloji ve Toksikoloji
dc.subjectYaşam Bilimleri (LIFE)
dc.titleFormulation of sustained release oral dosage forms of hydralazine hydrochloride for the treatment of hypertension and cancer
dc.typeBildiri
dc.contributor.departmentİstanbul Üniversitesi , ,
dc.contributor.firstauthorID593384


Files in this item

FilesSizeFormatView

There are no files associated with this item.

This item appears in the following Collection(s)

Show simple item record